Skip to main content

Fitbit receives FDA approval for the Fitbit Flow, a low-cost emergency ventilator for use during the COVID-19 pandemic

4 Jun, 2020
Fitbit, the company known for its fitness wearables, announced on Wednesday that it has received emergency use authorization (EUA) from the US Food & Drug Administration (FDA) for a new emergency ventilator, which Fitbit designed in response to the COVID-19 global health crisis.
An automatic resuscitator, Fitbit Flow was inspired by the MIT E-Vent Design Toolbox, and based on specifications for Rapidly Manufactured Ventilation Systems. Fitbit consulted with clinicians at Oregon Health & Science University and Mass General Brigham Center for COVID Innovation to design the new ventilator. The new emergency ventilator, the Fitbit Flow, will leverage Fitbit's existing global supply chain so it can scale rapidly if needed.